Skip to main content

Vaxart, Inc.

VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000072444

No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Vaxart, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
4
−1 vs. Q1 2026
Shares held
64.7K
+7.96K (+14.0%) vs. Q1 2026
Total value
$39.0K
+$4.82K (+14.1%) vs. Q1 2026
New holders
1
0 more added
Sold out
2
0 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VXRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 4 institutions
Q1 2021: 159 institutionsQ2 2021: 143 institutionsQ3 2021: 141 institutionsQ4 2021: 147 institutionsQ1 2022: 148 institutionsQ2 2022: 146 institutionsQ3 2022: 143 institutionsQ4 2022: 132 institutionsQ1 2023: 109 institutionsQ2 2023: 111 institutionsQ3 2023: 96 institutionsQ4 2023: 87 institutionsQ1 2024: 104 institutionsQ2 2024: 100 institutionsQ3 2024: 100 institutionsQ4 2024: 93 institutionsQ1 2025: 92 institutionsQ2 2025: 98 institutionsQ3 2025: 17 institutionsQ4 2025: 5 institutionsQ1 2026: 5 institutionsQ2 2026: 4 institutions
Value heldQ2 2026: $39.0K
Q1 2021: $195.1MQ2 2021: $260.6MQ3 2021: $297.5MQ4 2021: $267.9MQ1 2022: $226.3MQ2 2022: $155.6MQ3 2022: $110.7MQ4 2022: $42.6MQ1 2023: $25.8MQ2 2023: $21.1MQ3 2023: $13.9MQ4 2023: $9.38MQ1 2024: $52.3MQ2 2024: $27.0MQ3 2024: $31.9MQ4 2024: $23.7MQ1 2025: $11.1MQ2 2025: $10.3MQ3 2025: $839.9KQ4 2025: $22.2KQ1 2026: $34.2KQ2 2026: $39.0K
Institutions holding VXRT and their total value by quarter
QuarterHoldersValue
Q2 20264$39.0K
Q1 20265$34.2K
Q4 20255$22.2K
Q3 202517$839.9K
Q2 202598$10.3M
Q1 202592$11.1M
Q4 202493$23.7M
Q3 2024100$31.9M
Q2 2024100$27.0M
Q1 2024104$52.3M
Q4 202387$9.38M
Q3 202396$13.9M
Q2 2023111$21.1M
Q1 2023109$25.8M
Q4 2022132$42.6M
Q3 2022143$110.7M
Q2 2022146$155.6M
Q1 2022148$226.3M
Q4 2021147$267.9M
Q3 2021141$297.5M
Q2 2021143$260.6M
Q1 2021159$195.1M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Vaxart, Inc.; share changes are against Q1 2026.

Institutions holding VXRT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Heritage Wealth Advisors29,655$17.9K0.00%00.0%Unchanged
LVM Capital Management Ltd25,000$15.0K0.00%00.0%Unchanged
Kingswood Wealth Advisors, LLC10,005$6.05K0.00%+10,005New
Archer Investment Corp15$90.00%00.0%Unchanged
Golden State Equity Partners0$00.00%−2,000−100.0%Sold out
First Command Advisory Services, Inc.0$00.00%−40−100.0%Sold out